GLA and Fabry disease: The developed method was successfully applied to the determination of lyso-Gb3 concentrations in 55 plasma samples obtained from 34 patients with FD, 5 individuals carrying non-relevant polymorphisms of the GLA gene, and 16 sex-matched (8 males, 8 females) and age-matched (p = 0.334) healthy controls (Table 3).